Setbacks put drug firms under pressure
The pharmaceuticals sector was under pressure today after high-profile setbacks for AstraZeneca and GlaxoSmithKline spooked investors.
Shares in AstraZeneca plunged more than 8% after it ditched experimental stroke drug NXY-059 following its failure during clinical trials.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





